Freestone Grove Partners’s Capricor Therapeutics CAPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-22,920
Closed -$316K 605
2024
Q4
$316K Buy
+22,920
New +$316K ﹤0.01% 457